Personal information

Activities

Employment (1)

Novo Nordisk A/S: Søborg, DK

(Global Medical Affairs)
Employment
Source: Self-asserted source
Gowda A

Works (5)

Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5)

Annals of Internal Medicine
2023-11 | Journal article
Contributors: Harpreet S. Bajaj; Jens Aberle; Melanie Davies; Anders Meller Donatsky; Marie Frederiksen; Dilek G. Yavuz; Amoolya Gowda; Ildiko Lingvay; Bruce Bode
Source: check_circle
Crossref

Rationale and design of the phase 3 development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes

Diabetes, Obesity and Metabolism
2022-09-15 | Journal article
Part of ISSN: 1462-8902
Part of ISSN: 1463-1326
Contributors: Gowda A
Source: Self-asserted source
Gowda A
grade
Preferred source (of 2)‎

Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE

BMJ Open Diabetes Research & Care
2021-11 | Journal article
Part of ISSN: 2052-4897
Contributors: Gowda A
Source: Self-asserted source
Gowda A

Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100

Diabetes, Obesity and Metabolism
2021-08 | Journal article
Part of ISSN: 1462-8902
Part of ISSN: 1463-1326
Contributors: Gowda A
Source: Self-asserted source
Gowda A

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

Diabetes Care
2021-07-01 | Journal article
Part of ISSN: 0149-5992
Part of ISSN: 1935-5548
Contributors: Gowda A
Source: Self-asserted source
Gowda A